Explore company profiles, quarterly results, announcements and ownership disclosures.
Loading the company view…
Expleo Solutions Limited (NSE: EXPLEOSOL), ISIN INE201K01015 — earnings, PEAD surprise, concall summary, Walk-the-Talk management consistency, SAST and insider filings, and the EquiSense Score (ECS), all in plain English on EquiSense.
EXPLEOSOL last traded at ₹834.45 (+0.46%), with a 52-week range of ₹640.00 to ₹1175.10 (as of 6 Nov 2026).
Shareholding as of Sep 2026: promoters 71.05%, FIIs 0.16%, DIIs 0.40%, mutual funds 0.00%.
EquiSense Score (ECS): 80/100.
Data sourced from NSE and BSE filings. Educational — not investment advice.